MDT | Medtronic plc Stock Overview

(Stock Exchange: NYSE)

Day's Range	89.44 - 90.24
52 Week Range	68.84 - 91.49
Beta	0.69
Implied Volatility	27.81%
IV Rank	27.08%
Day's Volume	4,116,614
Average Volume	6,363,938
Shares Outstanding	1,282,490,000
Market Cap	115,443,337,350
Sector	Healthcare
Industry	Medical - Devices
IPO Date	1973-05-02

Valuation
Profitability
Growth
Health
P/E Ratio	30.31
Forward P/E Ratio	15.88
EPS	2.97
1YR Price Target	90.00
Dividend Yield	3.11%
Dividend Per Share	2.00
Dividend ExDate	2023-06-22
Dividend PayDate	2023-07-14
Employees	95,000
Country	Ireland
Website	MDT

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

MDT's peers: ABT, ALGN, AXNX, BFLY, BSX, DXCM, EW, INMD, MASS, ZBH, SYK, PODD, TNDM, NNOX, PHG, SENS

*Chart delayed

Analyzing fundamentals for MDT we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is very poor, Growth is very bad and Health is passable. For more detailed analysis please see MDT Fundamentals page.

Watching at MDT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on MDT Technicals page.